What is the current Organ Perfusion and Preservation market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Organ Perfusion and Preservation market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Organ Perfusion and Preservation market?

Increasing demand for organ transplantation and advances in preservation technologies drive the market.

What are the challenges faced by the Organ Perfusion and Preservation market?

Limited organ availability and high costs of preservation solutions are significant challenges.

Which regions are expected to lead the Organ Perfusion and Preservation market?

North America and Europe are expected to dominate the market due to high adoption rates.

Who are the top companies in the Organ Perfusion and Preservation market?

Top companies include Medtronic, Getinge, and Paragonix Technologies.

What future opportunities exist in the Organ Perfusion and Preservation market?

Emerging economies and increasing investments in research and development offer future opportunities.

How does technology impact the Organ Perfusion and Preservation market?

Advances in technologies like machine perfusion and normothermic preservation improve organ viability.

What is the regulatory landscape of the Organ Perfusion and Preservation market?

Regulatory bodies like FDA and EMA oversee the market, ensuring safety and efficacy of products.

What is the future outlook of the Organ Perfusion and Preservation market?

The market is expected to grow significantly, driven by increasing demand for organ transplantation.

Organ Perfusion and Preservation Growth Trends & Opportunity Analysis 2033

Organ Perfusion and Preservation by Application (Heart Preservation, Liver Preservation, Kidney Preservation, Lung Preservation), by Types (Organ Preservation Devices, Organ Preservation Solutions, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 140

Forecast Period: 2026 - 2033

Market Size: $262 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 140

Forecast Period: 2026 - 2033

Market Size: $262 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Organ Perfusion and Preservation Market Size | CAGR 7.5% Forecast 2033

Organ Perfusion and Preservation Growth Trends & Opportunity Analysis 2033

🏭 Healthcare🌍 Global

Pages: 140

Forecast Period: 2026 - 2033

Market Size: $262 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 140

Forecast Period: 2026 - 2033

Market Size: $262 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Organ Perfusion and Preservation Market Overview

The Organ Perfusion and Preservation market refers to the industry involved in the development and implementation of technologies and methods for preserving organs for transplantation. As the Organ Perfusion and Preservation market size is expected to reach $190 million by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by increasing demand for organ transplantation and advancements in preservation technologies. The industry expansion is anticipated to be shaped by key factors such as technology shifts, regulatory frameworks, and competitive intensity, with the largest region being North America and the fastest-growing region being Asia-Pacific.

Loading chart…

The Organ Perfusion and Preservation market is expected to experience a CAGR of 10.5% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of end-stage organ failure and the growing need for effective preservation methods. Key forces shaping the industry include technological advancements in machine perfusion, regulatory frameworks supporting the development of new preservation methods, and competitive intensity among market players. As the industry continues to evolve, strategic planners and business development teams must stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	262.00 million
Revenue forecast in 2033	456.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Organ Recovery Systems; XVIVO; Institut Georges Lopez; Paragonix Technologies; TransMedics; OrganOx; Bridge to Life; EBERS; Vascular Perfusion Solutions; TXInnovations; Dr. Franz Köhler Chemie GmbH; 21st Century Medicine; Preservation Solutions; Carnamedica; Global Transplant Solutions; SALF; Biochefa
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Organ Perfusion and Preservation market is experiencing significant growth, driven by advancements in medical technology and increasing demand for organ transplants. The market dynamics are influenced by various factors, including regulatory frameworks, competitive landscape, and macroeconomic trends.

Growth Drivers2 items

Advances in organ preservation techniques, such as normothermic perfusion, are improving the quality and availability of organs for transplantation, thereby driving the growth of the Organ Perfusion and Preservation market size.

The rising prevalence of chronic diseases, such as kidney disease and liver disease, is increasing the demand for organ transplants, which in turn is fueling the growth forecast of the Organ Perfusion and Preservation market.

Restraints2 items

The high cost of organ perfusion and preservation systems, as well as the limited reimbursement for these procedures, are significant restraints on the growth of the Organ Perfusion and Preservation market.

The shortage of skilled professionals with expertise in organ perfusion and preservation is also hindering the growth of the market, particularly in developing regions.

Opportunities2 items

The increasing adoption of organ perfusion systems in emerging economies presents a significant opportunity for market players to expand their customer base and increase their revenue share in the Organ Perfusion and Preservation market.

The development of novel preservation solutions, such as normothermic perfusion, is expected to further drive the growth of the Organ Perfusion and Preservation market size and improve patient outcomes.

Challenges2 items

The lack of standardization in organ perfusion and preservation protocols is a significant challenge facing the Organ Perfusion and Preservation market, as it can lead to variability in patient outcomes and limit the adoption of these technologies.

The ongoing COVID-19 pandemic has disrupted the supply chain and limited the availability of organs for transplantation, which has negatively impacted the growth forecast of the Organ Perfusion and Preservation market.

Market Segmentation

Loading chart…

The Organ Perfusion and Preservation market can be segmented based on application, which includes subtypes such as static cold storage, machine perfusion, and normothermic perfusion. Each of these subtypes contributes to the overall market size, with static cold storage being the most commonly used method. Understanding the Organ Perfusion and Preservation segmentation is crucial to determine the market size and growth potential. The application segment plays a significant role in the market, as it directly affects the demand for perfusion and preservation solutions.

The types of Organ Perfusion and Preservation solutions can be categorized into subtypes such as hypothermic machine perfusion, normothermic machine perfusion, and static cold storage. Each of these subtypes has its own advantages and disadvantages, and the choice of solution depends on the specific organ being preserved and the intended use. The types segment is critical in determining the market size, as it affects the demand for specific perfusion and preservation solutions. Analyzing the market taxonomy, including the types segment, is essential to understand the Organ Perfusion and Preservation market dynamics.

Organ Perfusion and Preservation Segmentation Breakdown9 items

Application

Heart Preservation

Liver Preservation

Kidney Preservation

Lung Preservation

Types

Organ Preservation Devices

Organ Preservation Solutions

Others

Regional Insights

Loading chart…

The Organ Perfusion and Preservation market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share, driven by factors such as high adoption rates, favorable policies, and significant investments in healthcare infrastructure. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing demographics, improving infrastructure, and growing ecosystem maturity.

Key drivers for each region include: for North America, high adoption rates, favorable policies, and significant investments in healthcare infrastructure; for Europe, increasing demographics, improving infrastructure, and growing ecosystem maturity; for Asia Pacific, large demographics, rising income levels, and expanding healthcare access; for Latin America, growing healthcare expenditure, increasing awareness about organ donation, and improving infrastructure; and for Middle East & Africa, rising income levels, expanding healthcare access, and growing government initiatives to promote organ donation and transplantation.

The regional forecast suggests that the Organ Perfusion and Preservation market will experience significant growth in the coming years, driven by increasing demand for organ transplantation and preservation solutions. The market is expected to be influenced by factors such as adoption rates, policies, investments, demographics, infrastructure, and ecosystem maturity, which will vary across regions.

Competitive Landscape

The Organ Perfusion and Preservation market is moderately consolidated, with a mix of global players and local companies competing for market share. The Organ Perfusion and Preservation competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local companies are concentrating on regional expansion and customization.

Companies in the Organ Perfusion and Preservation market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are focusing on the following strategies:

Organ Recovery Systems: regional expansion

XVIVO: innovation pipeline

Institut Georges Lopez: premium pricing

Paragonix Technologies: OEM tie-ups

TransMedics: vertical integration

OrganOx: local manufacturing

Key Organ Perfusion and Preservation Companies17 items

Organ Recovery Systems

XVIVO

Institut Georges Lopez

Paragonix Technologies

TransMedics

OrganOx

Bridge to Life

EBERS

Vascular Perfusion Solutions

TXInnovations

Dr. Franz Köhler Chemie GmbH

21st Century Medicine

Preservation Solutions

Carnamedica

Global Transplant Solutions

SALF

Biochefa

Market Ecosystem

The Organ Perfusion and Preservation ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. Value is created and captured through the development, integration, and application of perfusion and preservation technologies, which enable the effective storage and transportation of organs for transplantation. This ecosystem can be broadly segmented into three main categories: upstream technology providers and suppliers, midstream integrators and channels, and downstream end users.

Raw material/component suppliers — provide essential components

Technology providers — develop perfusion and preservation technologies

OEMs / manufacturers — produce perfusion and preservation systems

System integrators / EPCs — integrate systems for end users

Distributors / channel partners — distribute systems to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish standards and guidelines

In the Organ Perfusion and Preservation ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through stringent guidelines and approvals. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can vary by region. Switching costs and interoperability requirements also pose challenges, as end users may be locked into specific systems or technologies. A thorough value chain analysis is necessary to understand these dynamics and identify opportunities for innovation and growth.

Recent Industry Insights

The Organ Perfusion and Preservation industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading industry players have focused on advancing perfusion technologies and improving organ preservation methods. Notable mergers and acquisitions have also taken place, aiming to consolidate resources and expertise in the field. Furthermore, several product and technology launches have been announced, offering innovative solutions for organ preservation and perfusion.

Additionally, regulatory changes have been implemented to ensure the safe and effective use of perfusion and preservation technologies. A shift in consumer and enterprise trends has also been observed, with a growing emphasis on personalized medicine and organ transplantation. The industry has also seen significant funding rounds and expansions, driving research and development in the field. These developments are expected to shape the future of the Organ Perfusion and Preservation industry, driving growth and innovation in the years to come.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Organ Perfusion and Preservation market outlook. The market attractiveness is moderate, driven by increasing demand for organ transplantation and advancements in preservation technologies. Competitive intensity is high, with key players investing heavily in research and development to improve perfusion and preservation solutions.

The long-term outlook for the Organ Perfusion and Preservation market is positive, with innovations in machine perfusion and normothermic perfusion expected to drive growth. However, the demand–supply balance is a key concern, with shortages of donated organs and limited preservation capabilities. Key risk factors include regulatory challenges, high development costs, and technological failures. Overall, the Organ Perfusion and Preservation market outlook is promising, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Organ Perfusion and Preservation Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Organ Perfusion and Preservation Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Organ Perfusion and Preservation Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Heart Preservation

6.1.2. Liver Preservation

6.1.3. Kidney Preservation

6.1.4. Lung Preservation

6.2. Global Organ Perfusion and Preservation Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Organ Preservation Devices

6.2.2. Organ Preservation Solutions

6.2.3. Others

6.3. Global Organ Perfusion and Preservation Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Organ Perfusion and Preservation Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Organ Perfusion and Preservation Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Organ Perfusion and Preservation Market Competition by Key Manufacturers

8.1. Global Organ Perfusion and Preservation Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Organ Perfusion and Preservation: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Organ Recovery Systems

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. XVIVO

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Institut Georges Lopez

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Paragonix Technologies

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. TransMedics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. OrganOx

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Bridge to Life

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. EBERS

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Vascular Perfusion Solutions

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. TXInnovations

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Dr. Franz Köhler Chemie GmbH

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. 21st Century Medicine

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Preservation Solutions

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Carnamedica

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Global Transplant Solutions

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. SALF

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Biochefa

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Organ Perfusion and Preservation Market

Figure 4: Global Organ Perfusion and Preservation Market: Drivers

Figure 5: Global Organ Perfusion and Preservation Market: Challenges

Figure 6: Global Organ Perfusion and Preservation Market: Trends

Figure 7: Global Organ Perfusion and Preservation Market: Opportunity

Figure 8: Global Organ Perfusion and Preservation Market: Restraint

Figure 9: Global Organ Perfusion and Preservation Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Organ Perfusion and Preservation Market Value (USD Million) By Region

Figure 15: Global Organ Perfusion and Preservation Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Organ Perfusion and Preservation Market Value (USD Million) By Region

Figure 23: Global Organ Perfusion and Preservation Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global Organ Perfusion and Preservation Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Organ Perfusion and Preservation Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Organ Perfusion and Preservation Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Organ Perfusion and Preservation Market Value (USD Million) By Region

Table 10: Global Organ Perfusion and Preservation Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Organ Perfusion and Preservation Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Organ Perfusion and Preservation Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Organ Perfusion and Preservation Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Organ Recovery Systems Basic Information And Sales Area

Table 31: Organ Recovery Systems. Products Portfolio

Table 32: XVIVO Basic Information And Sales Area

Table 33: XVIVO. Products Portfolio

Table 34: Institut Georges Lopez Basic Information And Sales Area

Table 35: Institut Georges Lopez. Products Portfolio

Table 36: Paragonix Technologies Basic Information And Sales Area

Table 37: Paragonix Technologies. Products Portfolio

Table 38: TransMedics Basic Information And Sales Area

Table 39: TransMedics. Products Portfolio

Table 40: OrganOx Basic Information And Sales Area

Table 41: OrganOx. Products Portfolio

Table 42: Bridge to Life Basic Information And Sales Area

Table 43: Bridge to Life. Products Portfolio

Table 44: EBERS Basic Information And Sales Area

Table 45: EBERS. Products Portfolio

Table 46: Vascular Perfusion Solutions Basic Information And Sales Area

Table 47: Vascular Perfusion Solutions. Products Portfolio

Table 48: TXInnovations Basic Information And Sales Area

Table 49: TXInnovations. Products Portfolio

Table 50: Dr. Franz Köhler Chemie GmbH Basic Information And Sales Area

Table 51: Dr. Franz Köhler Chemie GmbH. Products Portfolio

Table 52: 21st Century Medicine Basic Information And Sales Area

Table 53: 21st Century Medicine. Products Portfolio

Table 54: Preservation Solutions Basic Information And Sales Area

Table 55: Preservation Solutions. Products Portfolio

Table 56: Carnamedica Basic Information And Sales Area

Table 57: Carnamedica. Products Portfolio

Table 58: Global Transplant Solutions Basic Information And Sales Area

Table 59: Global Transplant Solutions. Products Portfolio

Table 60: SALF Basic Information And Sales Area

Table 61: SALF. Products Portfolio

Table 62: Biochefa Basic Information And Sales Area

Table 63: Biochefa. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global Organ Perfusion and Preservation Market Value (USD Million) By Region

Table 69: Global Organ Perfusion and Preservation Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Organ Perfusion and Preservation Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	262.00 million
Revenue forecast in 2033	456.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Organ Recovery Systems; XVIVO; Institut Georges Lopez; Paragonix Technologies; TransMedics; OrganOx; Bridge to Life; EBERS; Vascular Perfusion Solutions; TXInnovations; Dr. Franz Köhler Chemie GmbH; 21st Century Medicine; Preservation Solutions; Carnamedica; Global Transplant Solutions; SALF; Biochefa
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options